Toshiba shows high-resolution vascular imaging technology for the Infinix i-series

Toshiba America Medical Systems (TAMS) has introduced a new version of 3D vascular imaging technology for its Infinix i-series line of vascular x-ray systems.

Developed in conjunction with neuroradiologists at Johns Hopkins University School of Medicine, TAMS is showing improvements on its previous 3D digital subtraction angiography (3D-DSA) technology of its Infinix i-series with a new 3D fusion digital subtraction angiography (3D-FDSA) technology. The new technology illustrates both intracranial vascular anomalies and detailed anatomic correlation with surrounding bone structures.

While the previous 3D-DSA technology enhanced the accuracy of DSA for the diagnosis of intracranial vascular anomalies, detailed anatomic information of surrounding bone structures was not provided. Toshiba's 3D-FDSA is a new algorithm for rotational angiography that combines separate reconstructions of blood vessels and bone structures in a single 3D representation. The fusion of 3D-DSA and 3D bone images produces a high-resolution 3D-FDSA image that is designed to accurately depict fine anatomic structures and topographic relationships.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.